Sales rise 8.60% to Rs 14405.22 crore
Net profit of Sun Pharmaceutical Industries rose 2.56% to Rs 3117.95 crore in the quarter ended September 2025 as against Rs 3040.16 crore during the previous quarter ended September 2024. Sales rose 8.60% to Rs 14405.22 crore in the quarter ended September 2025 as against Rs 13264.22 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 14405.22 | 13264.22 | 9 |
| OPM % | 31.43 | 29.70 | - |
| PBDT | 4897.11 | 4223.79 | 16 |
| PBT | 4167.61 | 3597.88 | 16 |
| NP | 3117.95 | 3040.16 | 3 |
Powered by Capital Market - Live News